1781 - 1790 of 5832 Results
Title
Year
- Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease2022OPENTitle: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000013218Best OA location URL: https://n.neurology.org/content/neurology/98/8/e859.full.pdfCitation Count: 59
-
OPENTitle: Functional characterization of the biogenic amine transporters on human macrophagesJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 7Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.151892Best OA location URL: http://insight.jci.org/articles/view/151892/files/pdfCitation Count: 22
- Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries2022OPENTitle: Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 CountriesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 303End Page: 318Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00313-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00313-9.pdfCitation Count: 7
- A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot Study2022OPENTitle: A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot StudyJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 6Issue #: 1Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000521232Best OA location URL: https://www.karger.com/Article/Pdf/521232Citation Count: 9
- Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognition2022OPENTitle: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognitionJournal Name: Brain, Behavior, and ImmunityPublisher: Elsevier BVVol: 101Issue #:Start Page: 182End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbi.2022.01.005Best OA location URL: https://doi.org/10.1016/j.bbi.2022.01.005Citation Count: 34
- Holocue: A Wearable Holographic Cueing Application for Alleviating Freezing of Gait in Parkinson's Disease2022OPENTitle: Holocue: A Wearable Holographic Cueing Application for Alleviating Freezing of Gait in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.628388Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.628388/pdfCitation Count: 16
-
OPENTitle: Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brainJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00509-5Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-021-00509-5Citation Count: 45
- Progressive Prefrontal Cortex Dysfunction in Parkinson's Disease With Probable REM Sleep Behavior Disorder: A 3-Year Longitudinal Study2022OPENTitle: Progressive Prefrontal Cortex Dysfunction in Parkinson's Disease With Probable REM Sleep Behavior Disorder: A 3-Year Longitudinal StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.750767Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.750767/pdfCitation Count: 15
- The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation2022OPENTitle: The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1778Issue #:Start Page: 147781End Page: 147781Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2022.147781Best OA location URL: https://research.rug.nl/files/199932071/1_s2.0_S0006899322000051_main.pdfCitation Count: 15
-
OPENTitle: Adenosine A2A Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 853End Page: 857Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28897Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28897Citation Count: 15